DEF: Phibro Animal Health Sets Nov. 3 Annual Meeting

Phibro Animal Health Corporation has announced its 2026 Annual Meeting of Stockholders, scheduled for November 3, 2026, to elect directors and ratify the appointment of its independent auditor.

Summary

• Phibro Animal Health Corporation is holding its 2026 Annual Meeting of Stockholders on November 3, 2026, at 9:00 AM Eastern Time in Teaneck, NJ.
• The meeting's agenda includes the election of three Class I Directors for a term expiring in 2029 and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2027.
• The record date for determining stockholders entitled to vote is September 11, 2026.
• The company is providing proxy materials electronically via the internet, with a Notice of Internet Availability mailed on or about September 21, 2026.
• The Board of Directors recommends a vote FOR the election of the nominated directors and FOR the ratification of the auditor.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, primarily due to the upcoming annual meeting and the routine ratification of the auditor, with no significant negative disclosures.

Positives

• Scheduled annual meeting to address key corporate governance matters.
• Board of Directors recommends favorable votes for director nominees and auditor ratification.
• Clear process outlined for stockholders to vote and access proxy materials.
• The company is utilizing electronic distribution of proxy materials, which is environmentally conscious and cost-effective.

Future Outlook

The filing primarily concerns the upcoming annual meeting and does not contain specific forward-looking financial guidance. The election of directors and ratification of the auditor are standard corporate governance procedures.

Management Comments

• "We appreciate your continued support of Phibro Animal Health Corporation."
• "Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon as possible."

Industry Context

StockSavvy.ai notes that this filing is typical for a publicly traded company as it prepares for its annual shareholder meeting. The focus on director elections and auditor ratification are standard governance practices within the animal health industry.

Management Changes

Corporate Governance

Related Party Transactions

• Mr. Jack C. Bendheim, his family members, and BFI Co., LLC hold significant voting power and economic interests in the company.
• Daniel M. Bendheim (son of Jack C. Bendheim) is nominated for election as a Class I Director and is the current President and CEO.
• Jonathan Bendheim (son of Jack C. Bendheim) is nominated for election as a Class I Director and is the current Executive Vice President, Talent, Technology and Business Development.
• Certain relatives of Jack C. Bendheim received aggregate compensation and benefits of $2.6 million for the fiscal year ended June 30, 2026, including Daniel M. Bendheim, Jonathan Bendheim, and Dr. Zev Jacobson.
• BFI Co., LLC has registration rights for its shares.
• The company has indemnification agreements with directors and officers.

Stakeholder Impact

• Shareholders will vote on director nominees and auditor ratification, influencing board composition and oversight.
• Employees' compensation and benefits are detailed in the Compensation Discussion and Analysis section.
• The company's controlled status may impact perceptions of corporate governance for certain investors.

Next Steps

• Stockholders to vote on the election of directors and ratification of the auditor.
• The company will hold its Annual Meeting of Stockholders on November 3, 2026.
• The company will file a Form 8-K with preliminary voting results within four business days after the Annual Meeting.

Key Dates

Recommendation

This filing is a routine proxy statement for an annual meeting and does not contain new financial performance data or strategic shifts that would warrant a buy or sell recommendation. The information presented is standard for corporate governance and director elections.

Keywords

Annual Meeting, Proxy Statement, Director Election, Independent Auditor, Corporate Governance, Stockholder Vote